- Home
- ITOS vs WTF Comparison
ITOS vs WTF Comparison
Compare ITOS & WTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- WTF
- Stock Information
- Founded
- ITOS 2011
- WTF 1989
- Country
- ITOS United States
- WTF Hong Kong
- Employees
- ITOS N/A
- WTF N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- WTF
- Sector
- ITOS Health Care
- WTF
- Exchange
- ITOS Nasdaq
- WTF NYSE
- Market Cap
- ITOS 381.2M
- WTF 315.5M
- IPO Year
- ITOS 2020
- WTF 2025
- Fundamental
- Price
- ITOS $10.18
- WTF $5.64
- Analyst Decision
- ITOS Hold
- WTF
- Analyst Count
- ITOS 6
- WTF 0
- Target Price
- ITOS $10.60
- WTF N/A
- AVG Volume (30 Days)
- ITOS 911.6K
- WTF 105.8K
- Earning Date
- ITOS 08-07-2025
- WTF 01-01-0001
- Dividend Yield
- ITOS N/A
- WTF N/A
- EPS Growth
- ITOS N/A
- WTF N/A
- EPS
- ITOS N/A
- WTF 0.04
- Revenue
- ITOS $35,000,000.00
- WTF $10,508,879.00
- Revenue This Year
- ITOS N/A
- WTF N/A
- Revenue Next Year
- ITOS N/A
- WTF N/A
- P/E Ratio
- ITOS N/A
- WTF $152.10
- Revenue Growth
- ITOS 177.89
- WTF 4482.47
- 52 Week Low
- ITOS $4.80
- WTF $4.05
- 52 Week High
- ITOS $18.13
- WTF $19.85
- Technical
- Relative Strength Index (RSI)
- ITOS 67.57
- WTF N/A
- Support Level
- ITOS $9.95
- WTF N/A
- Resistance Level
- ITOS $10.20
- WTF N/A
- Average True Range (ATR)
- ITOS 0.15
- WTF 0.00
- MACD
- ITOS -0.09
- WTF 0.00
- Stochastic Oscillator
- ITOS 90.00
- WTF 0.00
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About WTF WATON FINANCIAL LIMITED
Waton Financial Ltd is a holding company that operates its business through subsidiaries in the securities brokerage and distribution services, margin financing services, and other ancillary services business; Software licensing and related support services, including licensing of trading platform applications, upgrades and enhancements, maintenance; and other associated services to securities brokers and financial institutions. The group also provided software licensing and related support services, including licensing trading platform applications, and others.